David Maggs

Efficacy and Metabolic Effects of Metformin and Troglitazone in Type II Diabetes Mellitus

Silvio E. Inzucchi, David Maggs, Geralyn Spollett et al. · New England Journal of Medicine · 1998 · 799 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years

David C. Klonoff, John B. Buse, Loretta L. Nielsen et al. · Current Medical Research and Opinion · 2007 · 700 citations

Medicine, Endocrinology, Pharmacology +13

Amylin replacement with pramlintide as an adjunct to insulin therapy improves long‐term glycaemic and weight control in Type 1 diabetes mellitus: a 1‐year, randomized controlled trial

Robert E. Ratner, Richard A. Dickey, Mark Fineman et al. · Diabetic Medicine · 2004 · 307 citations

Medicine, Endocrinology, Pharmacotherapy +17

Pramlintide as an Adjunct to Insulin Therapy Improves Long-Term Glycemic and Weight Control in Patients With Type 2 Diabetes

Priscilla Hollander, Philip T. Levy, Mark Fineman et al. · Diabetes Care · 2003 · 301 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

Metabolic Effects of Troglitazone Monotherapy in Type 2 Diabetes Mellitus

David Maggs · Annals of Internal Medicine · 1998 · 287 citations

Medicine, Pharmacology, Pharmacotherapy +16